VAV1 |
VAV1, VAV: Proto-oncogene vav |
CRKL |
CRKL: Crk-like protein |
38.160 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
38.160 |
Evidence |
|
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
CFL1 |
CFL1, CFL: Cofilin-1 |
38.160 |
Evidence |
|
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
38.160 |
Evidence |
|
FGA |
IPI00021885 |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
38.160 |
Evidence |
|
HDAC3 |
HDAC3: Histone deacetylase 3 |
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
38.160 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
38.160 |
Evidence |
|
RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
38.160 |
Evidence |
|
MBD3 |
MBD3: Methyl-CpG-binding domain protein 3 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
38.160 |
Evidence |
|
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
DOK1 |
DOK1: Docking protein 1 |
38.160 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
38.160 |
Evidence |
O
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
STK38L |
STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like |
38.160 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
38.160 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
PIP5K3 |
PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase |
38.160 |
Evidence |
|
H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIRA |
HIRA, DGCR1, HIR, TUPLE1: Protein HIRA |
38.160 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
38.160 |
Evidence |
|
CCNB1 |
Cyclin B1 |
AKAP8L |
AKAP8L, NAKAP95, HRIHFB2018: A-kinase anchor protein 8-like |
38.160 |
Evidence |
|
AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
38.160 |
Evidence |
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
38.160 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
38.160 |
Evidence |
O
|
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
38.160 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
CRKL |
CRKL: Crk-like protein |
38.160 |
Evidence |
|
NRAS |
NRAS, HRAS1: GTPase NRas precursor |
STK3 |
STK3, MST2: Serine/threonine-protein kinase 3 |
38.160 |
Evidence |
|
RPLP0 |
RPLP0: 60S acidic ribosomal protein P0 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
38.090 |
Evidence |
|
LCP1 |
LCP1, PLS2: Plastin-2 |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
38.080 |
Evidence |
|